Journal
FUTURE CARDIOLOGY
Volume 14, Issue 2, Pages 131-141Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/fca-2017-0074
Keywords
BNP; cardiac biomarkers; cTnI; cTnT; electrochemical technique; multiplexed detection; near-patient test; point-of-care; rapid; zinc oxide nanostructure
Categories
Funding
- Enlisense LLC
Ask authors/readers for more resources
Aim: Development of a label-free multiplexed point-of-care diagnostic device for a panel of cardiac biomarkers - cardiac troponin-T (cTnT), troponin-I (cTnI) and B-type natriuretic peptide (BNP). Methods: A nonfaradaic electrochemical immunoassay designed with anisotropic high surface area ZnO nanostructures grown using low-temperature hydrothermal methods was selectively immobilized with capture antibodies. Multiplexed detection in human serum using ZnO nanostructures based on complementary electrochemical measurement techniques - electrochemical impedance spectroscopy and Mott-Schottky. Results: Linear signal response for detection of three biomarkers in human serum with dynamic range of 1 pg/ml-100 ng/ml and limit of detection at 1 pg/ml and low signal response to background interferences was achieved. Conclusion: First demonstration of simultaneous detection of three cardiac biomarkers in clinically relevant range with sensor's analytical performance and linear response of detection showed potential utility in screening clinical samples for early diagnosis of acute myocardial infarction and chronic heart failure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available